Patients with medullary thyroid cancer or MEN2 history should not use GLP-1 therapies
Cost-effectiveness analyses indicate that semaglutide 2.4 mg is economically viable in high-income countries due to reductions in diabetes progression, cardiovascular events and healthcare utilization[15]
Coffee is not disappearing
[DOI] [PMC free article] [PubMed] [Google Scholar] 29.Olsson B., Johansson M., Gabrielsson J., Bolme P
References Zeyner, A., & Harmeyer, J
Sulfur burps on Ozempic (semaglutide 0.5-2 mg): Incidence, Severity, and Realistic Expectations Sulfur burps on Ozempic (semaglutide 0.5-2 mg): Incidence, Severity, and Realistic Expectations At a glance Reported incidence (trial data): Eructation reported in approximately 6-8% of participants at the 1 mg dose and up to ~7% at 2 mg in the SUSTAIN trial program